This report describes and explains the preventive healthcare technologies and services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global preventive healthcare technologies and services market reached a value of nearly $2,96,479.6 million in 2024, having grown at a compound annual growth rate (CAGR) of 10.12% since 2019. The market is expected to grow from $2,96,479.6 million in 2024 to $6,17,766.51 million in 2029 at a rate of 15.82%. The market is then expected to grow at a CAGR of 14.16% from 2029 and reach $1.19 trillion in 2034.
Growth in the historic period resulted from the integration of artificial intelligence in diagnostics, expansion of telemedicine services, advancements in genomic medicine and implementation of smart hospital technologies. Factors that negatively affected growth in the historic period were regulatory and alignment challenges and barriers to innovation in healthcare institutions.
Going forward, the integration of blockchain for health data security, expansion of population health management solutions, growth of digital therapeutics and government initiatives and public awareness will drive the growth. Factor that could hinder the growth of the preventive healthcare technologies and services market in the future include data security and privacy concerns and unequal access to healthcare services.
Asia-Pacific was the largest region in the preventive healthcare technologies and services market, accounting for 31.93% or $94.65 billion of the total in 2024. It was followed by North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the preventive healthcare technologies and services market will be Asia-Pacific and Middle East where growth will be at CAGRs of 17.93% and 16.86% respectively. These will be followed by South America and Africa where the markets are expected to grow at CAGRs of 16.49% and 15.71% respectively.
The global preventive healthcare technologies and services market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 4.23% of the total market in 2023. GlaxoSmithKline (GSK) was the largest competitor with a 0.99% share of the market, followed by Abbott Laboratories with 0.68%, Medtronic plc with 0.50%, Becton Dickinson (BD) with 0.47%, Merck & Co. Inc. with 0.41%, Koninklijke Philips N.V. with 0.31%, McKesson Corporation with 0.24%, Omnicell Inc. with 0.22%, Sanofi SA with 0.21% and Omron Healthcare Inc. with 0.208%.
The preventive healthcare technologies and services market is segmented by type into early detection and screening technologies, vaccines, chronic disease management technologies and advanced technologies to reduce errors. The early detection and screening technologies market was the largest segment of the preventive healthcare technologies and services market segmented by type, accounting for 36.70% or $108.81 billion of the total in 2024. Going forward, the chronic disease management technologies segment is expected to be the fastest growing segment in the preventive healthcare technologies and services market segmented by type, at a CAGR of 18.15% during 2024-2029.
The preventive healthcare technologies and services market is segmented by application into hospitals and clinics. The hospitals market was the largest segment of the preventive healthcare technologies and services market segmented by application, accounting for 60.13% or $178.26 billion of the total in 2024. Going forward, the clinics segment is expected to be the fastest growing segment in the preventive healthcare technologies and services market segmented by application, at a CAGR of 16.83% during 2024-2029.
The top opportunities in the preventive healthcare technologies and services market segmented by type will arise in the early detection and screening technologies segment, which will gain $1,25,787.52 millions of global annual sales by 2029. The top opportunities in the preventive healthcare technologies and services market segmented by application will arise in the hospitals segment, which will gain $1,82,221.09 millions of global annual sales by 2029. The preventive healthcare technologies and services market size will gain the most in the USA at $72.29 billion.
Market-trend-based strategies for the preventive healthcare technologies and services market include integration of artificial intelligence in early disease detection, expansion of telemedicine and mobile health (mHealth) services, proliferation of wearable health monitoring devices, adoption of digital twin technology for personalized preventive care, rise of gut microbiome testing for preventive nutrition and expansion of workplace preventive health programs using biometrics.
Player-adopted strategies in the preventive healthcare technologies and services market include focus on global market expansion through competitive pricing and strategic product launches, focus on innovation-driven expansion through strategic acquisitions and advanced medical technology development, and focus on partnerships to enhance blood collection and diagnostic technologies.
To take advantage of the opportunities, the analyst recommends the preventive healthcare technologies and services to focus on advancing AI-driven early detection and personalization, focus on expanding integration of wearable technologies for personalized preventive care, focus on integrating digital twin technology for personalized preventive care, focus on personalized gut microbiome testing for preventive care, focus on expanding preventive health solutions for corporate wellness programs, expand in emerging markets, continue to focus on developed markets, focus on expanding distribution through digital platforms and regional partnerships, focus on aligning pricing with value-based care and affordability, focus on building awareness through targeted digital campaigns, focus on educating through partnerships with institutions and communities and focus on targeting end-users through personalization and education.
The global preventive healthcare technologies and services market reached a value of nearly $2,96,479.6 million in 2024, having grown at a compound annual growth rate (CAGR) of 10.12% since 2019. The market is expected to grow from $2,96,479.6 million in 2024 to $6,17,766.51 million in 2029 at a rate of 15.82%. The market is then expected to grow at a CAGR of 14.16% from 2029 and reach $1.19 trillion in 2034.
Growth in the historic period resulted from the integration of artificial intelligence in diagnostics, expansion of telemedicine services, advancements in genomic medicine and implementation of smart hospital technologies. Factors that negatively affected growth in the historic period were regulatory and alignment challenges and barriers to innovation in healthcare institutions.
Going forward, the integration of blockchain for health data security, expansion of population health management solutions, growth of digital therapeutics and government initiatives and public awareness will drive the growth. Factor that could hinder the growth of the preventive healthcare technologies and services market in the future include data security and privacy concerns and unequal access to healthcare services.
Asia-Pacific was the largest region in the preventive healthcare technologies and services market, accounting for 31.93% or $94.65 billion of the total in 2024. It was followed by North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the preventive healthcare technologies and services market will be Asia-Pacific and Middle East where growth will be at CAGRs of 17.93% and 16.86% respectively. These will be followed by South America and Africa where the markets are expected to grow at CAGRs of 16.49% and 15.71% respectively.
The global preventive healthcare technologies and services market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 4.23% of the total market in 2023. GlaxoSmithKline (GSK) was the largest competitor with a 0.99% share of the market, followed by Abbott Laboratories with 0.68%, Medtronic plc with 0.50%, Becton Dickinson (BD) with 0.47%, Merck & Co. Inc. with 0.41%, Koninklijke Philips N.V. with 0.31%, McKesson Corporation with 0.24%, Omnicell Inc. with 0.22%, Sanofi SA with 0.21% and Omron Healthcare Inc. with 0.208%.
The preventive healthcare technologies and services market is segmented by type into early detection and screening technologies, vaccines, chronic disease management technologies and advanced technologies to reduce errors. The early detection and screening technologies market was the largest segment of the preventive healthcare technologies and services market segmented by type, accounting for 36.70% or $108.81 billion of the total in 2024. Going forward, the chronic disease management technologies segment is expected to be the fastest growing segment in the preventive healthcare technologies and services market segmented by type, at a CAGR of 18.15% during 2024-2029.
The preventive healthcare technologies and services market is segmented by application into hospitals and clinics. The hospitals market was the largest segment of the preventive healthcare technologies and services market segmented by application, accounting for 60.13% or $178.26 billion of the total in 2024. Going forward, the clinics segment is expected to be the fastest growing segment in the preventive healthcare technologies and services market segmented by application, at a CAGR of 16.83% during 2024-2029.
The top opportunities in the preventive healthcare technologies and services market segmented by type will arise in the early detection and screening technologies segment, which will gain $1,25,787.52 millions of global annual sales by 2029. The top opportunities in the preventive healthcare technologies and services market segmented by application will arise in the hospitals segment, which will gain $1,82,221.09 millions of global annual sales by 2029. The preventive healthcare technologies and services market size will gain the most in the USA at $72.29 billion.
Market-trend-based strategies for the preventive healthcare technologies and services market include integration of artificial intelligence in early disease detection, expansion of telemedicine and mobile health (mHealth) services, proliferation of wearable health monitoring devices, adoption of digital twin technology for personalized preventive care, rise of gut microbiome testing for preventive nutrition and expansion of workplace preventive health programs using biometrics.
Player-adopted strategies in the preventive healthcare technologies and services market include focus on global market expansion through competitive pricing and strategic product launches, focus on innovation-driven expansion through strategic acquisitions and advanced medical technology development, and focus on partnerships to enhance blood collection and diagnostic technologies.
To take advantage of the opportunities, the analyst recommends the preventive healthcare technologies and services to focus on advancing AI-driven early detection and personalization, focus on expanding integration of wearable technologies for personalized preventive care, focus on integrating digital twin technology for personalized preventive care, focus on personalized gut microbiome testing for preventive care, focus on expanding preventive health solutions for corporate wellness programs, expand in emerging markets, continue to focus on developed markets, focus on expanding distribution through digital platforms and regional partnerships, focus on aligning pricing with value-based care and affordability, focus on building awareness through targeted digital campaigns, focus on educating through partnerships with institutions and communities and focus on targeting end-users through personalization and education.
Major Market Trends
- Integration of Artificial Intelligence in Early Disease Detection
- Expansion of Telemedicine and Mobile Health (mHealth) Services
- Proliferation of Wearable Health Monitoring Devices
- Adoption of Digital Twin Technology for Personalized Preventive Care
- Rise of Gut Microbiome Testing for Preventive Nutrition
- Expansion of Workplace Preventive Health Programs Using Biometrics
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Preventive Healthcare Technologies and Services Growth Analysis and Strategic Analysis Framework
9 Global Preventive Healthcare Technologies and Services Market Segmentation
10 Preventive Healthcare Technologies and Services Market, Regional and Country Analysis
11 Asia-Pacific Market
12 Western Europe Market
13 Eastern Europe Market
14 North America Market
15 South America Market
16 Middle East Market
17 Africa Market
18 Competitive Landscape and Company Profiles
19 Other Major and Innovative Companies
22 Key Mergers and Acquisitions
23 Recent Developments in the Preventive Healthcare Technologies and Services Market
24 Opportunities and Strategies
25 Preventive Healthcare Technologies and Services Market, Conclusions and Recommendations
26 Appendix
Executive Summary
Preventive Healthcare Technologies and Services Global Market Opportunities and Strategies to 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global preventive healthcare technologies and services market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for global preventive healthcare technologies and services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The global preventive healthcare technologies and services market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider global preventive healthcare technologies and services market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type and by application.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis and Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional and Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type and by application in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities and Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations- This section includes recommendations for preventive healthcare technologies and services market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
1) by Type: Early Detection and Screening Technologies; Vaccines; Chronic Disease Management Technologies; Advanced Technologies to Reduce Errors
2) by Applications: Hospitals; Clinics
Key Companies Profiled: GlaxoSmithKline (GSK); Abbott Laboratories; Medtronic plc; Becton Dickinson (BD); Merck & Co. Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; preventive healthcare technologies and services indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
The companies featured in this Preventive Healthcare Technologies and Services market report include:- GlaxoSmithKline (GSK)
- Abbott Laboratories
- Medtronic plc
- Becton Dickinson (BD)
- Merck & Co. Inc.
- Koninklijke Philips N.V.
- McKesson Corporation
- Omnicell Inc.
- Sanofi SA
- Omron Healthcare Inc.
- Pro Medicus
- Sonic Healthcare
- ResMed
- Mindray
- WeDoctor
- Ping An Good Doctor
- AliHealth
- CitiusTech
- PharmEasy
- 1mg
- Halodoc
- Alodokter
- KlikDokter
- SehatQ
- Olympus Corporation
- Terumo Corporation
- Hoya Corporation
- Sysmex Corporation
- Nihon Kohden
- Doctor Anywhere
- WhiteCoat
- Homage
- Vuno
- AItrics
- LifeSemantics
- MediHeroes
- HUINNO Healthcare
- Siemens Healthineers
- Philips Healthcare
- Cera Care
- HealthHero
- Neko Health
- Tolion Health, Inc.
- Prosoma
- CliniNote
- Roche
- Nanonets Health
- Zebra
- Lyra Health
- Spring Health
- Headspace
- PointClickCare
- Fullscript
- AlayaCare
- Momentum Health
- Ualá
- Naranja X
- Nubank
- Banco Bradesco
- Banco Santander
- Banco Falabella
- Excel Credit
- Banco de Crédito del Perú (BCP)
- Banco Falabella Per
- Teva Pharmaceuticals
- Medtronic
- Check-Cap
- Insightec
- Cerner Middle East
- Medcare Hospitals & Medical Centres
- Aster DM Healthcar
- Sehatech
- Vezeeta
- Hi Pharma
- CureMD
- Mediclinic International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 293 |
| Published | April 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 296.47 Billion |
| Forecasted Market Value ( USD | $ 1190 Billion |
| Compound Annual Growth Rate | 15.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 76 |
